Association of calcitriol and blood pressure in normotensive men

Hypertension

Volumn 30, Issue 5, 1997, Pages 1289-1294

  Kristal Boneh, Estela ^a   Froom, Paul ^a,b   Harari, Gil ^a   Ribak, Joseph ^a,b  

^a Occupational Health and Rehabilitation Institute Israel   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Blood pressure; Lead; Vitamin D

Indexed keywords

CALCITRIOL; CALCIUM; LEAD; PARATHYROID HORMONE;

ADULT; ARTICLE; BLOOD PRESSURE; DIASTOLIC BLOOD PRESSURE; HORMONE BLOOD LEVEL; HUMAN; MALE; NORMAL HUMAN; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

EID: 0030700528     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.30.5.1289     Document Type: Article

References (46)

1. Stumpf WE, O'Brien LP. 1,25(OH)2 vitamin D3 sites of action in the brain: an autoradiographic study. Histochemistry. 1987;87: 393-406.
2. Stumpf WE. Steroid hormones and the cardiovascular system: direct actions of estradiol, progesterone, testosterone, gluco- and mineralocorticoids, and soltriol (vitamin D) on central nervous regulatory and peripheral tissues. Experientia. 1990;46:13-25.
3. Merke J, Hofmann W, Goldschmidt D, Ritz E. Demonstration of 1,25 (OH)2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int. 1987;41:112-114.
4. Merke J, Milde P, Lewicka S, Hugel U, Klaus G, Mangelsdorf DJ, Haussler MR, Rauterberg EW, Ritz E. Identification and regulation of 1,25-dihydroxyvitamin D3 receptor activity and biosynthesis of 1,25-dihydroxyvitamin D: studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest. 1989; 8:1903-1915.
5. Clark SA, Stumpf WE, Bishop CW, DeLuca HF, Park DH, Joh TH. The adrenal: a new target organ of the calcitropic hormone 1,25-dihydroxyvitamin D3. Cell Tissue Res. 1986;243:299-302.
6. Kawashima H. Receptor for 1,25 dihydroxyvitamin D in a vascular smooth muscle cell line derived from rat aorta. Biochem Biophys Res Commun. 1987;146:1-6.
7. Campese VM. Calcium, parathyroid hormone, and blood pressure. Am J Hypertens. 1989;2:34S-44S.
8. Young EW, McCarron DA, Morris C. Calcium regulating hormones in essential hypertension. Importance of gender. Am J Hypertens. 1990;3:161S-166S.
9. Resnick LM, Muller FB, Laragh JH. Calcium-regulating hormones in essential hypertension: Relation to plasma renin activity and sodium metabolism. Ann Intern Med. 1986;105:649-653.
10. Brickman AS, Nyby MD, von Hungen K, Eggena P, Tuck ML. Calcitropic hormones, platelet calcium, and blood pressure in essential hypertension. Hypertension. 1990;16:515-522.
11. Merke J, Lucas PA, Szabo A, Cournot-Witmer G, Mall G, Bouillon R, Drueke T, Mann J, Rita E. Hyperparathyroidism and abnormal calcitriol metabolism in the spontaneously hypertensive rat. Hypertension. 1989;13:233-242.
12. Kurtz TW, Portale AA, Morris RC. Evidence for a difference in vitamin D metabolism between spontaneously hypertensive and Wistar-Kyoto rats. Hypertension. 1986;8:1015-1020.
13. Sowers MR, Wallace RB, Hollis BW, Lemke JH. Relationship between 1,25-dihydroxyvitamin D and blood pressure in a geographically defined population. Am J Clin Nutr. 1988;48;1053-1056.
14. Orwoll ES, Oviatt S. Relationship of mineral metabolism and long-term calcium and cholecalciferol supplementation to blood pressure in normotensive men. Am J Clin Nutr. 1990;52:717-721.
15. Dietel M, Dorn G, Montz R, Altenahr E. Influence of vitamin D3, 1,25-dihydroxyvitamin D3 and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion, adenosine 3,5 monophosphate release and ultrastructure of parathyroid glands in organ culture. Endocrinology. 1979;105:237-245.
16. Kristal-Boneh E, Harari G, Green M, Ribak J. Summer-winter variation in 24-h ambulatory blood pressure. Blood Press Monitoring. 1996;1:87-94.
17. Sherman SS, Hollis BW, Tobin JD. Vitamin D status and related parameters in a healthy population: the effects of age, sex and season. J Clin Endocrinol Metab. 1990;71:405-413.
18. Modan M, Lubin F, Lusky A, Chetrit A, Fuchs Z, Halkin H. Interrelationships of obesity, habitual diet, physical activity and glucose intolerance in the four main Israeli Jewish ethnic groups. In: Berry EM, Blondheim SH, Eliahou HE, Shafrir E, eds. The Israel Glucose Intolerance, Obesity Research: V. London, UK: John Libbey & Co; 1986:46-53.
19. Viskoper JR, ed. Manual of Nonpharmacological Control of Hypertension. Berlin, Germany: Springer Verlag; 1990:95.
20. Kingsley GR. The direct biuret method for determination of serum proteins as applied to photoelectric and visual colorimetry. J Lab Clin Med. 1942;27:840-845.
21. Corcoran RM, Durnan SM. Albumin determination by a modified bromcresol green method. Clin Chem. 1977;23:765.
22. Weissman N, Pileggi VJ. Inorganic ions. In: Henry RJ, Cannon DC, Winkelman JW, eds. Clinical Chemistry. 2nd edition. Hagerstown, Md: Harper & Row; 1974:646-653.
23. Fernandez FJ. Micromethod for lead determination in whole blood by atomic absorption with use of the graphite furnace. Clin Chem. 1975;21:558-561.
24. SAS Institute Inc. SAS language: reference, Version 6, 1st edition. Cary, NC: SAS Institute Inc; 1989:638.
25. Mason HJ, Somervaille LJ, Wright AL, Chettle DR, Scott MC. Effects of occupational lead exposure on serum 1,25-dihydroxyvitamin D levels. Hum Exp Toxicol. 1990;9:29-34.
26. Harlan WR, Landis JR, Schmouder RL, Goldstein NG, Harlan LC. Blood lead and blood pressure: relationship in the adolescent and adult US population. JAMA. 1985;253:530-534.
27. Lind L, Pollare A, Hvarfner A, Lithell H, Sorensen OH, Ljunghall S. Long-term treatment with active vitamin D (alphacalodiol) in middle-age men with impaired glucose tolerance: effects on insulin secretion and sensitivity, glucose tolerance and blood pressure. Diabetes Res. 1989;11:141-147.
28. Lind L, Wengle B, Ljunghall S. Blood pressure is lowered by vitamin D (alfacalcidiol) during long-term treatment of patients with intermittent hypercalcaemia. Acta Med Scand. 1987;222:423-427.
29. Lind L, Lithell H, Skarfors E, Wide L, Ljnghall S. Reduction of blood pressure by treatment with alphacalcidiol: a double-blind, placebo-controlled study in subjects with impaired glucose tolerance. Acta Med Scand. 1988;223:211-217.
30. Resnick LM, Laragh JH. Short-term effects of 1,25-dihydroxy vitamin D3 on blood pressure in essential hypertension. Kidney Int. 1984;26:206. Abstract.
31. Buhring M, Rodiger E, Reuter H, Bechhofer G. Cardiovascular advantages of an insolation with UVB. In: Passchier WF, Bosnajakovic BFM, eds. Human Exposure to Ultraviolet Radiation: Risks and Regulations. Amsterdam, Netherlands: Elsevier Science Publishers BV; 1984:113-116.
32. McCarron DA, Pingree PA, Rubin RJ, Gaucher SM, Molitch ME, Krutzik S. Enhanced parathyroid function in essential hypertension: a homeostatic response to a urinary calcium leak. Hypertension. 1980;2:162-168.
33. Zacariah PK, Schwartz GL, Strong CG, Ritter SG. Parathyroid hormone and calcium: a relationship in hypertension. Am J Hypertens. 1988:1:79S-82S.
34. Grobbee DE, Hackeng WHL, Birkenhager JC, Hofman A. Raised plasma intact parathyroid hormone concentrations in young people with mildly raised blood pressure. Br Med J. 1988;296:814-816.
35. Hughes MR, Haussler MR. 1,25-dihydroxyvitamin D3 receptors in parathyroid glands. J Biol Chem. 1978;253:1065-1073.
36. Boland R, Norman A, Ritz H, Hasselbach WF. Presence of 1,25-dihydroxyvitamin D3 receptor in chick skeletal muscle myoblasts. Biochem Biophys Res Comm. 1985;128:305-311.
37. Bukoski R, Lucas P, Drueke T, McCarron D. Theoretical mechanisms of dietary calcium's antihypertensive action. Adv Exp Med Biol. 1986;208:389-396.
38. Duprez D, de Buyzere M, de Backer T, Clement D. Relationship between vitamin D3 and the peripheral circulation in moderate arterial primary hypertension. Blood Press. 1994;3:389-393.
39. Simpson RU. Evidence for a specific 1,25-dihydroxyvitamin D3 receptor in rat heart. Circulation. 1983;68:239. Abstract.
40. Walters MR, Cuneo DL, Jamison AP. Possible significance of new target tissues for 1,25-dihydroxyvitamin D3. J Steroid Biochem. 1983;19:913-920.
41. Walters MR, Wicker DC, Riggle PC. 1,25-dihydroxyvitamin D3 receptors identified in the rat heart. J Mol Cell Cardiol. 1983;18:67-72.
42. DiPette DJ, Greilich PE, Nickols GA, Graham GA, Green A, Cooper CW, Holland OB. Effect of dietary calcium supplementation on blood pressure and calcitropic hormones in mineralocorticoid-salt hypertension. J Hypertens. 1990;8:515-520.
43. Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin P-H, Karanja N, for the DASH Collaborative Research Group. A clinical trial of the effects of dietary patterns on blood pressure. N Engl J Med. 1997;336:1117-1124.
44. Gallagher HJ, Riggs BL, Eisman J, Hamstra A, Arnaud SB, De Luca HF. Intestinal calcium absorption and serum vitamin D in normal subjects and osteporotic patients. J Clin Invest. 1979;64:729-736.
45. Kristal-Boneh E, Froom P, Harari G, Shapiro Y, Green MS. Seasonal changes in blood red cell parameters. Br J Haematol. 1993;85:603-607.
46. Kristal-Boneh E, Froom P, Harari G, Ribak J. Seasonal differences in blood cell parameters and the association with cigarette smoking. Lab Clin Haematol. In press.